174 related articles for article (PubMed ID: 25703259)
1. Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: in vitro analysis.
Gooding M; Malhotra M; McCarthy DJ; Godinho BM; Cryan JF; Darcy R; O'Driscoll CM
Eur J Pharm Sci; 2015 Apr; 71():80-92. PubMed ID: 25703259
[TBL] [Abstract][Full Text] [Related]
2. RVG-peptide-linked trimethylated chitosan for delivery of siRNA to the brain.
Gao Y; Wang ZY; Zhang J; Zhang Y; Huo H; Wang T; Jiang T; Wang S
Biomacromolecules; 2014 Mar; 15(3):1010-8. PubMed ID: 24547943
[TBL] [Abstract][Full Text] [Related]
3. Polyion complex micelles composed of pegylated polyasparthydrazide derivatives for siRNA delivery to the brain.
Huo H; Gao Y; Wang Y; Zhang J; Wang ZY; Jiang T; Wang S
J Colloid Interface Sci; 2015 Jun; 447():8-15. PubMed ID: 25689522
[TBL] [Abstract][Full Text] [Related]
4. PEGylated cyclodextrins as novel siRNA nanosystems: correlations between polyethylene glycol length and nanoparticle stability.
Godinho BM; Ogier JR; Quinlan A; Darcy R; Griffin BT; Cryan JF; O'Driscoll CM
Int J Pharm; 2014 Oct; 473(1-2):105-12. PubMed ID: 24992319
[TBL] [Abstract][Full Text] [Related]
5. Modified cyclodextrin-based nanoparticles mediated delivery of siRNA for huntingtin gene silencing across an in vitro BBB model.
Mendonça MCP; Cronin MF; Cryan JF; O'Driscoll CM
Eur J Pharm Biopharm; 2021 Dec; 169():309-318. PubMed ID: 34793942
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of cationic amphiphilic cyclodextrins for neuronal delivery of siRNA: effect of reversing primary and secondary face modifications.
O'Mahony AM; Doyle D; Darcy R; Cryan JF; O'Driscoll CM
Eur J Pharm Sci; 2012 Dec; 47(5):896-903. PubMed ID: 23022516
[TBL] [Abstract][Full Text] [Related]
7. Cyclodextrin-siRNA conjugates as versatile gene silencing agents.
Malhotra M; Gooding M; Evans JC; O'Driscoll D; Darcy R; O'Driscoll CM
Eur J Pharm Sci; 2018 Mar; 114():30-37. PubMed ID: 29191522
[TBL] [Abstract][Full Text] [Related]
8. Cationic and PEGylated Amphiphilic Cyclodextrins: Co-Formulation Opportunities for Neuronal Sirna Delivery.
O'Mahony AM; Ogier J; Darcy R; Cryan JF; O'Driscoll CM
PLoS One; 2013; 8(6):e66413. PubMed ID: 23805220
[TBL] [Abstract][Full Text] [Related]
9. A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor.
Fitzgerald KA; Malhotra M; Gooding M; Sallas F; Evans JC; Darcy R; O'Driscoll CM
Int J Pharm; 2016 Feb; 499(1-2):131-145. PubMed ID: 26721726
[TBL] [Abstract][Full Text] [Related]
10. A click chemistry route to 2-functionalised PEGylated and cationic β-cyclodextrins: co-formulation opportunities for siRNA delivery.
O'Mahony AM; Ogier J; Desgranges S; Cryan JF; Darcy R; O'Driscoll CM
Org Biomol Chem; 2012 Jul; 10(25):4954-60. PubMed ID: 22614240
[TBL] [Abstract][Full Text] [Related]
11. Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukemia: Physicochemical Characteristics, in Vitro Mechanistic Studies, and ex Vivo Patient Derived Therapeutic Efficacy.
Guo J; Russell EG; Darcy R; Cotter TG; McKenna SL; Cahill MR; O'Driscoll CM
Mol Pharm; 2017 Mar; 14(3):940-952. PubMed ID: 28146632
[TBL] [Abstract][Full Text] [Related]
12. Transvascular delivery of small interfering RNA to the central nervous system.
Kumar P; Wu H; McBride JL; Jung KE; Kim MH; Davidson BL; Lee SK; Shankar P; Manjunath N
Nature; 2007 Jul; 448(7149):39-43. PubMed ID: 17572664
[TBL] [Abstract][Full Text] [Related]
13. In vitro investigations of the efficacy of cyclodextrin-siRNA complexes modified with lipid-PEG-Octaarginine: towards a formulation strategy for non-viral neuronal siRNA delivery.
O'Mahony AM; Desgranges S; Ogier J; Quinlan A; Devocelle M; Darcy R; Cryan JF; O'Driscoll CM
Pharm Res; 2013 Apr; 30(4):1086-98. PubMed ID: 23192687
[TBL] [Abstract][Full Text] [Related]
14. Co-Formulation of Amphiphilic Cationic and Anionic Cyclodextrins Forming Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukaemia.
Kont A; Mendonça MCP; Cronin MF; Cahill MR; O'Driscoll CM
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077202
[TBL] [Abstract][Full Text] [Related]
15. RVG peptide as transfection reagent for specific cdk4 gene silencing in vitro and in vivo.
Rohn S; Suttkus A; Arendt T; Ueberham U
J Drug Target; 2012 May; 20(4):381-8. PubMed ID: 22443811
[TBL] [Abstract][Full Text] [Related]
16. Early-stage development of novel cyclodextrin-siRNA nanocomplexes allows for successful postnebulization transfection of bronchial epithelial cells.
Hibbitts A; O'Mahony AM; Forde E; Nolan L; Ogier J; Desgranges S; Darcy R; MacLoughlin R; O'Driscoll CM; Cryan SA
J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):466-77. PubMed ID: 24665866
[TBL] [Abstract][Full Text] [Related]
17. Click-modified cyclodextrins as nonviral vectors for neuronal siRNA delivery.
O'Mahony AM; Godinho BM; Ogier J; Devocelle M; Darcy R; Cryan JF; O'Driscoll CM
ACS Chem Neurosci; 2012 Oct; 3(10):744-52. PubMed ID: 23077718
[TBL] [Abstract][Full Text] [Related]
18. Formulation and Evaluation of Anisamide-Targeted Amphiphilic Cyclodextrin Nanoparticles To Promote Therapeutic Gene Silencing in a 3D Prostate Cancer Bone Metastases Model.
Evans JC; Malhotra M; Fitzgerald KA; Guo J; Cronin MF; Curtin CM; O'Brien FJ; Darcy R; O'Driscoll CM
Mol Pharm; 2017 Jan; 14(1):42-52. PubMed ID: 28043128
[TBL] [Abstract][Full Text] [Related]
19. Targeted brain delivery of itraconazole via RVG29 anchored nanoparticles.
Chen W; Zhan C; Gu B; Meng Q; Wang H; Lu W; Hou H
J Drug Target; 2011 Apr; 19(3):228-34. PubMed ID: 20540685
[TBL] [Abstract][Full Text] [Related]
20. Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review.
Chaturvedi K; Ganguly K; Kulkarni AR; Kulkarni VH; Nadagouda MN; Rudzinski WE; Aminabhavi TM
Expert Opin Drug Deliv; 2011 Nov; 8(11):1455-68. PubMed ID: 21867463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]